Intellus Advisors’s Johnson & Johnson JNJ Stock Holding History

Intellus Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$901K	Sell	3,684 -458	-11%	-$107K	0.12%	51
2025 Q4	$857K	Buy	4,142 +1	+0%	+$198	0.11%	56
2025 Q3	$768K	Sell	4,141 -117	-3%	-$20K	0.11%	60
2025 Q2	$650K	Buy	4,258 +207	+5%	+$31.8K	0.1%	69
2025 Q1	$672K	Buy	4,051 +2	+0%	+$313	0.12%	61
2024 Q4	$586K	Buy	+4,049	New	+$627K	0.1%	69

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Intellus Advisors's JNJ Position: Q1 2026 in Review

Intellus Advisors reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $107K and leaving 3,684 shares worth $901K. The position accounts for 0.12% of the portfolio, ranked #51.

Intellus Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Intellus Advisors held 3,684 shares of Johnson & Johnson worth $901K as of Q1 2026.
Intellus Advisors sold 458 Johnson & Johnson shares in Q1 2026, an estimated $107K.
Johnson & Johnson made up 0.12% of Intellus Advisors's portfolio in Q1 2026, its #51 holding.
Intellus Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Intellus Advisors's 13F filing for Q1 2026, filed 7 May 2026.